NeuroVive Pharmaceutical AB announced the appointment of Mark Farmery (PhD) as Vice President Business Development. Dr. Farmery will report to CEO Erik Kinnman and will join the company's management team. Dr. Farmery is a senior executive focused on biopharma business development, with more than 16 years' experience in asset scouting and evaluation, negotiation and project and alliance management. He has an extensive deal-making track record across pharma, biotech and academia in multiple therapeutic areas. Prior to joining NeuroVive, Dr. Farmery has held various business development positions at Karolinska Institutet Innovations AB, AstraZeneca and Karo Bio AB.